Tag: Christopher Stepanian

ANDIPen

Windgap Medical Announces Partnership with ALK-Abelló to Commercialize Novel ‘Wet/Dry’ Epinephrine...

Novel auto-injector is designed to address many unmet patient needs like portability, temperature stability, ease-of-use, and long shelf-life.
Windgap-ANDI

Developer of Revolutionary "Powder" Epinephrine Auto-Injector Raises $12 Million

Windgap Medical is securing funding to continue development.

Delivering the Next Generation Auto-Injector

CEO Christopher Stepanian tells us how Windgap's auto-injector seeks to 'improve the quality of life for patients living with severe allergies.'